000 02099nam  2200409zi 4500
0019.915290
003CaOODSP
00520221101123821
006m     o  d f      
007cr mn|||||||||
008220909e202209  onc     ob   f000 0 eng d
020 |a9780660454047 |q(report)
020 |a9780660454054 |q(summary)
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aHP40-323/2022E-PDF
0861 |aHP40-323/2022-1E-PDF
24500|aNACI rapid response : |bupdated interim guidance on Imvamune® in the context of ongoing monkeypox outbreaks.
2463 |aNational Advisory Committee on Immunization rapid response : |bupdated interim guidance on Imvamune® in the context of ongoing monkeypox outbreaks
264 1|aOttawa, ON : |bPublic Health Agency of Canada = Agence de la santé publique du Canada, |cSeptember 2022.
264 4|c©2022
300 |a1 online resource (27 pages) + |esummary (7 pages)
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aIssued also in French under title: Réponse rapide du CCNI : mise à jour des directives provisoires sur l'Imvamuneᴹᴰ dans le contexte des éclosions actuelles de variole simienne.
500 |aOn cover: An advisory committee statement (ACS), National Advisory Committee on Immunization (NACI).
500 |a"Pub.: 220414."
500 |a"Pub.: 220416."
504 |aIncludes bibliographical references (pages 20-23).
650 0|aHuman monkeypox|xVaccination|zCanada.
650 0|aHuman monkeypox|xVaccination|xGovernment policy|zCanada.
7102 |aPublic Health Agency of Canada, |eissuing body.
7101 |aCanada. |bNational Advisory Committee on Immunization, |eissuing body.
77508|tRéponse rapide du CCNI : |w(CaOODSP)9.915289
85640|qPDF|s1.53 MB|uhttps://publications.gc.ca/collections/collection_2022/aspc-phac/HP40-323-2022-eng.pdf|z(report)
85640|qPDF|s1.25 MB|uhttps://publications.gc.ca/collections/collection_2022/aspc-phac/HP40-323-2022-1-eng.pdf|z(summary)